Usefulness of Platelet to Lymphocyte Ratio for Predicting Recurrence of Atrial Fibrillation After Direct Current Cardioversion

Annals of Noninvasive Electrocardiology - United Kingdom
doi 10.1111/anec.12616
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Ischemic Stroke After Direct-Current Cardioversion for Defibrillation in Paroxysmal Atrial Fibrillation

Nosotchu
2009English

Plasma miRNA-155 Levels Predict Atrial Fibrillation Recurrence After Cardioversion

Heart Surgery Forum
SurgeryCardiovascular MedicineCardiology
2019English

Takotsubo Cardiomyopathy as a Sequela of Elective Direct-Current Cardioversion for Atrial Fibrillation

Texas Heart Institute Journal
MedicineCardiovascular MedicineCardiology
2014English

Effect of Atrial Fibrillation Duration on Probability of Immediate Recurrence After Transthoracic Cardioversion

Journal of the American College of Cardiology
Cardiovascular MedicineCardiology
2003English

Is There Any Link Between Vitamin D and Recurrence of Atrial Fibrillation After Cardioversion?

Brazilian Journal of Cardiovascular Surgery
MedicineSurgeryCardiovascular MedicineCardiology
2020English

Serum Levels of Vitamin E Are Associated With Early Recurrence of Atrial Fibrillation After Electric Cardioversion

Circulation: Arrhythmia and Electrophysiology
MedicineCardiovascular MedicinePhysiologyCardiology
2012English

The Presence of Fragmented QRS May Predict the Recurrence of Nonvalvular Atrial Fibrillation After Successful Electrical Cardioversion

Annals of Noninvasive Electrocardiology
MedicineCardiovascular MedicinePhysiologyCardiology
2019English

Responsiveness of AF6, a New, Short, Validated, Atrial Fibrillation-Specific Questionnaire—symptomatic Benefit of Direct Current Cardioversion

Journal of Interventional Cardiac Electrophysiology
MedicineCardiovascular MedicinePhysiologyCardiology
2010English

Left Ventricular Diastolic Function After Electrical Cardioversion of Atrial Fibrillation

Heart
2002English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy